Document:

ex_123925.htm

Exhibit 10.1

 

 

OFFICE LEASE AND ADMINISTRATIVE SUPPORT AGREEMENT

 

THIS OFFICE LEASE AND ADMINISTRATIVE SUPPORT AGREEMENT (this "Agreement") is made on September 13, 2018, by and between MedAmerica Properties Inc. ("MedAmerica") and Boca Equity Partners LLC ("BEP").

 

WHEREAS: The parties desire to provide for a cost-sharing arrangement relating to Banyan's use of a portion of BEP's offices located at 5200 Town Center Circle, Tower 1, Suite 550, Boca Raton, FL 33846 (the "Premises"), and certain overhead items at the Premises such as space, utilities and other administrative services.

 

NOW THEREFORE, the parties agree as follows:

 

TERMS

 

	 	
			1.

				
			Term. The term of this Agreement shall be month-to-month, commencing on September 1, 2018 (the "Effective Date"). The office lease and administrative support agreement dated June 8, 2017 between MedAmerica and BEP is terminated effective September 1, 2018.

			

 

	 	
			2.

				
			Shared Costs. BEP shall furnish to MedAmerica the following:

			

 

	 	
			a.

				
			A portion of the Premises, including related janitorial, electrical and other, associated taxes and utility services;

			

	 	
			b.

				
			Certain furniture, furnishings, computers and other equipment;

			

	 	
			c.

				
			Telephone service, internet access and postage machine, etc.;

			

	 	
			d.

				
			Services of Nancy Goss and other general office and administrative support.

			

 

	 	
			3.

				
			Reimbursement of Shared Costs. MedAmerica agrees to reimburse BEP $5,000 per month in advance for the costs of the services and facilities provided hereunder. If the cost of such services and facilities changes subsequently, the parties will negotiate changes in good faith.

			

 

	 	
			4.

				
			Notices. All notices, request, demands and other communications required or permitted under this Agreement shall be given in writing as follows:

			

 

	
			Boca Equity Partners, LLC

			5200 Town Center Circle

			Tower 1, Suite 550

			Boca Raton, FL 33486

			Attn: Gary O. Marino, CEO

				
			MedAmerica Properties Inc.

			5200 Town Center Circle

			Tower 1, Suite 550

			Boca Raton, FL 33486

			Attn: Patricia K. Sheridan CFO

			

 

Agreed upon as of the Effective Date:

 

	
			Boca Equity Partners LLC

				
			 

				
			MedAmerica Properties Inc.

			
	
			/s/ Gary O. Marino

				
			 

				
			/s/ Patricia K. Sheridan

			
	
			By: Gary O. Marino, CEO

				
			 

				
			By: Patricia K. Sheridan, CFO

			

 

1Exhibit 10.1

 

Execution Version

 

VOTING AND SUPPORT AGREEMENT

 

This VOTING AND SUPPORT
AGREEMENT (this “Agreement”), dated as of September [—],
2018, is by and between Xynomic Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the Persons
set forth on Schedule A (each a “Shareholder” and collectively, the “Shareholders”).
Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Merger
Agreement (as defined below).

 

WHEREAS, as of the
date hereof, each Shareholder is the holder of the number of ordinary shares, no par value, of Bison Capital Acquisition Corp.,
a British Virgin Islands company limited by shares (which shall domesticate as a Delaware corporation prior to the Closing) (“Parent”)
(such shares, together with, from and after the effective time of the Domestication (as defined below), shares of common stock,
par value $0.0001 per share, of Parent, being referred to herein collectively as “Parent Ordinary Shares”) and/or
options or warrants to purchase Parent Ordinary Shares (“Options”), in each case, set forth opposite the Shareholder’s
name on Schedule A (all such Parent Ordinary Shares set forth on Schedule A, together with any Parent Ordinary Shares
that are issued upon exercise of Options or otherwise hereafter issued to or otherwise acquired or owned by each Shareholder prior
to the termination of this Agreement being referred to herein as such Shareholder’s “Subject Shares”);

 

WHEREAS, certain Shareholders
are parties to a letter agreement with Parent dated June 19, 2017 (the “Letter Agreement”), pursuant to which
that such Shareholders have agreed, among others, to vote all Subject Shares beneficially owned by such Shareholder, in favor of
a Business Combination of Parent;

 

WHEREAS, pursuant to
the Letter Agreement, certain Shareholders have escrowed their respective Subject Shares in an escrow account in accordance with
the terms and conditions set forth in an escrow agreement among Parent, such Shareholders and Continental Stock Transfer &
Trust Company, dated June 19, 2017 (the “Escrow Agreement”);

 

WHEREAS, Parent, Bison
Capital Merger Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of Parent (“Merger Sub”),
the Company and Yinglin Mark Xu (“Xu”), an individual residing in Shanghai, China, solely in his capacity as
the representative for the Company’s stockholders (the “Stockholder Representative”), propose to enter
into an Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”), which provides,
among other things, for the merger of Merger Sub with and into the Company, with the Company surviving as a wholly owned subsidiary
of Parent (the “Merger”), upon the terms and subject to the conditions set forth in the Merger Agreement;

 

WHEREAS, at least one
day prior to the Closing and subject to the conditions of the Merger Agreement, Parent shall domesticate as a Delaware corporation
in accordance with Section 388 of the Delaware General Corporation Law, as amended, and Section 184 of the BVI Companies Act and
shall no longer be considered a company incorporated in the British Virgin Islands (the “Domestication”); and

 

WHEREAS, as a condition
to its willingness to enter into the Merger Agreement, the Company has required that each Shareholder, and as an inducement and
in consideration therefor, each Shareholder (in the Shareholder’s capacity as a holder of Subject Shares) has agreed to,
enter into this Agreement.

 

NOW, THEREFORE, in
consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth below and for
other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending
to be legally bound, do hereby agree as follows:

 

    	 	1	 

     

    

 

Article
I

VOTING AGREEMENT; GRANT OF PROXY

 

Each Shareholder hereby
covenants and agrees that:

 

1.01 Voting of Subject
Shares. Subject to the remaining terms of this Section 1.01, at every meeting of the holders of Parent Ordinary Shares (the
“Parent Shareholders”), however called, and at every adjournment or postponement thereof (or pursuant to a written
consent if the Parent Shareholders act by written consent in lieu of a meeting), each Shareholder shall, or shall cause the holder
of record on any applicable record date to, be present (in person or by proxy) and to vote such Shareholder’s Subject Shares
in favor of (a)  approval of the Merger Agreement, (b) (x)  approval of the Domestication and (y) adoption of the Domesticated
Parent Charter, (c) approval of the change of the name of Parent with effect from the Closing to “Xynomic Pharmaceuticals
Holdings, Inc.”, (d)  adoption and approval of the Certificate of Incorporation of the Surviving Company with effect
from the Closing, (e) the assumption by Parent of the Company Stock Incentive Plan, that provides for the granting of Parent Ordinary
Shares to employees of the Company and Parent or certain Subsidiaries of the Company and Parent in the form of stock options, restricted
stock units, restricted stock or other equity-based awards, (f) election of nine members of the Parent Board with effect from the
Closing, (g) adoption and approval of an amended and restated certificate of incorporation of Domesticated Parent substantially
in the form of Exhibit O to the Merger Agreement to be filed immediately following the Closing, (h) adoption and approval
of amended and restated bylaws of Domesticated Parent substantially in the form of Exhibit P to the Merger Agreement to
take effect immediately following the Closing, (i) approval to obtain any and all other approvals necessary or advisable to effect
the consummation of the Merger (the proposals set forth in the forgoing clauses (a) through (i) are referred to as the “Parent
Proposals”), (j) any proposal to adjourn or postpone the meeting to a later date, if there are not sufficient votes for
the approval of the Parent Proposals, including the issuance of Parent Ordinary Shares pursuant to the Merger Agreement, on the
date on which such meeting is held, and (k) any other proposal included in the Proxy Statement in connection with, or related to,
the consummation of the Merger for which the Parent Board has recommended that the Parent Shareholders vote in favor.

 

1.02 No Inconsistent
Arrangements. Except as expressly permitted or required hereunder or under the Merger Agreement or to the extent applicable,
except as expressly permitted or required under the Escrow Agreement and the Letter Agreement , such Shareholder shall not, directly
or indirectly, without Parent’s prior written consent, (a) create any Lien other than restrictions imposed by applicable
Law or pursuant to this Agreement on any Subject Shares, (b) transfer, sell, assign, gift or otherwise dispose of (collectively,
“Transfer”), or enter into any contract with respect to any Transfer of such Shareholder’s Subject Shares
or any interest therein, (c) grant or permit the grant of any proxy, power of attorney or other authorization in or with respect
to such Shareholder’s Subject Shares, (d) deposit or permit the deposit of such Shareholder’s Subject Shares into
a voting trust or enter into a voting agreement or arrangement with respect to such Shareholder’s Subject Shares or (e) take
any action that would make any representation or warranty of the Shareholder herein untrue or incorrect in any material respect,
or have the effect of preventing the Shareholder from performing such Shareholder’s obligations hereunder. Notwithstanding
the foregoing, the Shareholder may make Transfers of such Shareholder’s Subject Shares (x) by will, operation of law, or
for estate planning or charitable purposes, (y) to stockholders, direct or indirect affiliates (within the meaning set forth in
Rule 405 under the Securities Act), current or former partners (general or limited), members or managers of such Shareholder, as
applicable, or to the estates of any such stockholders, affiliates, partners, members or managers, or to another corporation, partnership,
limited liability company or other business entity that controls, is controlled by or is under common control with such Shareholder,
or (z) if such Shareholder is a trust, to any beneficiary of such Shareholder or the estate of any such beneficiary; provided that
in each such case, the Subject Shares shall continue to be bound by this Agreement and provided that each transferee agrees in
writing to be bound by the terms and conditions of this Agreement and either such Shareholder or the transferee provides the Company
with a copy of such agreement promptly upon consummation of any such Transfer.

 

1.03 Documentation
and Information. Such Shareholder shall permit and hereby authorizes the Company and Parent to publish and disclose in all
documents and schedules filed with the SEC, and any press release or other disclosure document that the Company or Parent reasonably
determines to be necessary in connection with the Merger and any transactions contemplated by the Merger Agreement, such Shareholder’s
identity and ownership of the Subject Shares and the nature of such Shareholder’s commitments and obligations under this
Agreement. Parent is an intended third-party beneficiary of this Section 1.03.

 

    	 	2	 

     

    

 

1.04 No Solicitation
of Transactions. Without limiting and subject to the provisions of Section 4.14 hereof, such Shareholder shall not, directly
or indirectly, knowingly take any action that Parent is not permitted to take pursuant to Section 7.08 of the Merger Agreement.

 

1.05 No Obligation
as Director or Officer. Nothing in this Agreement shall be construed to impose any obligation or limitation on votes or actions
taken by any director, officer, employee, agent or other representative of any Shareholder or by any Shareholder that is a natural
person, in each case, in his or her capacity as a director or officer of Parent.

 

Article
II

REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDER

 

Each Shareholder represents
and warrants to the Company, as to himself/herself/itself only, that:

 

2.01 Authorization;
Binding Agreement. Such Shareholder has full legal capacity, right and authority to execute and deliver this Agreement and
to perform such Shareholder’s obligations hereunder and to consummate the transactions contemplated hereby. Such Shareholder
has full power and authority to execute, deliver and perform this Agreement. This Agreement has been duly and validly executed
and delivered by such Shareholder, and constitutes a valid and binding obligation of such Shareholder enforceable against such
Shareholder in accordance with its terms, except as enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium
or other legal requirements relating to or affecting creditors’ rights generally or by equitable principles (regardless of
whether enforcement is sought at law or in equity).

 

2.02 Ownership of
Subject Shares; Total Shares. Such Shareholder is the record or beneficial owner (as defined in Rule 13d-3 under the Exchange
Act) of such Shareholder’s Subject Shares and has good and marketable title to such Subject Shares free and clear of any
Lien (including any restriction on the right to vote or otherwise transfer such Subject Shares), except (a) as provided hereunder,
(b) pursuant to any applicable restrictions on transfer under the Securities Act, (c) as subject to any risk of forfeiture with
respect to any Parent Ordinary Shares granted to such Shareholder under an agreement with or employee benefit plan of Parent and
(d) with respect to Options, as provided pursuant to the terms of the Option and any stock option plan under which such Option
was granted. Such Shareholder’s Subject Shares constitute all of the Parent Ordinary Shares and/or Options owned by such
Shareholder as of the date hereof. Except pursuant to this Agreement, no Person has any contractual or other right or obligation
to purchase or otherwise acquire any of such Shareholder’s Subject Shares.

 

2.03 Voting Power.
Except as may be set forth on Schedule A, such Shareholder has full voting power, with respect to such Shareholder’s
Subject Shares, and full power of disposition, full power to issue instructions with respect to the matters set forth herein and
full power to agree to all of the matters set forth in this Agreement, in each case with respect to all of such Shareholder’s
Subject Shares. None of such Shareholder’s Subject Shares are subject to any proxy, voting trust or other agreement or arrangement
with respect to the voting of such Subject Shares, except as provided hereunder.

 

2.04 Reliance.
Such Shareholder has had the opportunity to review the Merger Agreement and this Agreement with counsel of such Shareholder’s
own choosing. Such Shareholder understands and acknowledges that the Company is entering into the Merger Agreement in reliance
upon such Shareholder’s execution, delivery and performance of this Agreement.

 

2.05 Absence of Litigation.
With respect to such Shareholder, as of the date hereof, there is no action, suit, investigation or proceeding pending against,
or, to the knowledge of such Shareholder, threatened against, such Shareholder or any of such Shareholder’s properties or
assets (including such Shareholder’s Subject Shares) that could reasonably be expected to prevent, delay or impair the ability
of such Shareholder to perform its obligations hereunder or to consummate the transactions contemplated hereby.

 

    	 	3	 

     

    

 

Article
III

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

The Company represents
and warrants to the Shareholder that:

 

3.01 Organization;
Authorization. The Company is a corporation duly incorporated and registered under the Laws of the State of Delaware. The consummation
of the transactions contemplated hereby are within the Company’s corporate powers and have been duly authorized by all necessary
corporate actions on the part of the Company. The Company has full power and authority to execute, deliver and perform this Agreement.

 

3.02 Binding Agreement.
This Agreement has been duly authorized, executed and delivered by the Company and constitutes a valid and binding obligation of
the Company enforceable against the Company in accordance with its terms, except as enforceability may be limited by bankruptcy,
insolvency, reorganization, moratorium or other legal requirements relating to or affecting creditors’ rights generally or
by equitable principles (regardless of whether enforcement is sought at law or in equity).

 

3.03 No Conflicts.

 

(a) No filing with, or
notification to, any Governmental Entity, and no consent, approval, authorization or permit of any other person is necessary for
the execution of this Agreement by the Company and the consummation by the Company of the transactions contemplated hereby.

 

(b) None of the execution
and delivery of this Agreement by the Company, the consummation by the Company of the transactions contemplated hereby or compliance
by the Company with any of the provisions hereof shall (i) conflict with or result in any breach of the organizational documents
of the Company, (ii) result in, or give rise to, a violation or breach of or a default under any of the terms of any material
contract, understanding, agreement or other instrument or obligation to which the Company is a party or by which the Company or
any of its assets may be bound, or (iii) violate any applicable order, writ, injunction, decree, law, statute, rule or regulation
of any Governmental Entity, except for any of the foregoing as would not reasonably be expected to impair the Company’s ability
to perform its obligations under this Agreement in any material respect.

 

Article
IV

MISCELLANEOUS

 

4.01 Notices.
All notices, requests and other communications to either party hereunder shall be in writing (including facsimile transmission)
and shall be given, (a) if to the Company, in accordance with the provisions of the Merger Agreement and (b) if to the Shareholder,
to the Shareholder’s address set forth on a signature page hereto, or to such other address as the Shareholder may hereafter
specify in writing to the Company for such purpose.

 

4.02 Termination.
This Agreement shall terminate automatically and become void and of no further force or effect, without any notice or other action
by any Person, upon the earliest of (a) as to each Shareholder, the mutual written consent of the Company and such Shareholder,
(b) the termination of the Merger Agreement in accordance with its terms and (c) the Effective Time. Upon termination
of this Agreement, neither party shall have any further obligations or liabilities under this Agreement; provided, however, that
(i) nothing set forth in this Section 4.02 shall prevent either party from seeking any remedies (at law or in equity) against another
party or relieve either party from liability for any breach of this Agreement prior to termination hereof and (ii) the provisions
of this Article IV shall survive any termination of this Agreement.

 

    	 	4	 

     

    

 

4.03 Amendments and
Waivers. Any provision of this Agreement may be amended or waived if such amendment or waiver is in writing and is signed,
in the case of an amendment, by each party to this Agreement or, in the case of a waiver, by the party against whom the waiver
is to be effective. No failure or delay by either party in exercising any right, power or privilege hereunder shall operate as
a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise
of any other right, power or privilege.

 

4.04 Binding Effect;
Benefit; Assignment. The provisions of this Agreement shall be binding upon and shall inure to the benefit of the parties hereto
and their respective successors and permitted assigns. Except as set forth in Section 1.03, no provision of this Agreement is intended
to confer any rights, benefits, remedies, obligations or liabilities hereunder upon any person other than the parties hereto and
their respective successors and assigns. Neither party may assign, delegate or otherwise transfer any of its rights or obligations
under this Agreement without the consent of the other party hereto.

 

4.05 Governing Law;
Venue. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware without regard
to principles of conflicts of law that would result in the application of the substantive law of another jurisdiction. Each party
hereby irrevocably submits to the exclusive jurisdiction of the Court of Chancery of the State of Delaware (or, if the Court of
Chancery of the State of Delaware declines to accept jurisdiction over a particular matter, any federal court within the State
of Delaware, or, if no federal court in the State of Delaware accepts jurisdiction, any state court within the State of Delaware)
(the “Delaware Courts”) over all claims or causes of action (whether in contract or tort, in law or in equity,
or granted by statute or otherwise) that may be based upon, arise out of or relate to this Agreement and any other document or
instrument delivered pursuant to this Agreement, or the negotiation, execution, termination, validity, interpretation, construction,
enforcement, performance or nonperformance of this Agreement or otherwise arising from the transactions contemplated hereby or
the relationship among the parties (including any claim or cause of action based upon, arising out of or related to any representation
or warranty made in or in connection with, or as an inducement to enter into, this Agreement) (collectively, “Related
Claims”), and each party hereby irrevocably agrees that all Related Claims may be heard and determined in such courts.
Each party hereby irrevocably and unconditionally waives, to the fullest extent permitted by applicable Law, any objection which
it may now or hereafter have to the laying of venue of any such Related Claim brought in any such court or any defense of inconvenient
forum for the maintenance of such dispute. Each party agrees that a judgment in any such dispute may be enforced in other jurisdictions
by suit on the judgment or in any other manner provided by law. Each party hereby consents to process being served by any other
party in any Related Claim by the delivery of a copy thereof in accordance with the provisions of Section 4.01 (other than by email)
along with a notification that service of process is being served in conformance with this Section 4.05. Nothing in this Agreement
will affect the right of any party to serve process in any other manner permitted by law. EACH OF THE PARTIES TO THIS AGREEMENT
HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION
(A) ARISING UNDER THIS AGREEMENT OR (B) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO
IN RESPECT OF THIS AGREEMENT OR ANY OF THE TRANSACTIONS RELATED HERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING,
AND WHETHER IN CONTRACT, TORT, EQUITY OR OTHERWISE. EACH OF THE PARTIES TO THIS AGREEMENT HEREBY AGREES AND CONSENTS THAT ANY SUCH
CLAIM, DEMAND, ACTION OR CAUSE OF ACTION WILL BE DECIDED BY COURT TRIAL WITHOUT A JURY, AND THAT THE PARTIES TO THIS AGREEMENT
MAY FILE A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR
RIGHT TO TRIAL BY JURY.

 

4.06 Counterparts.
This Agreement may be executed simultaneously in two or more counterparts, each of which will be deemed an original, but all of
which will constitute one agreement. Execution and delivery of this Agreement by exchange of electronically transmitted counterparts
bearing the signature of a party will be equally as effective as delivery of a manually executed counterpart of such party.

 

    	 	5	 

     

    

 

4.07 Entire Agreement.
This Agreement constitutes the entire agreement between the parties with respect to the subject matter of this Agreement and supersedes
all prior agreements and understandings, both oral and written, between the parties with respect to its subject matter.

 

4.08 Severability.
Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction will not affect the
validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending term
or provision in any other situation or in any other jurisdiction.

 

4.09 Specific Performance.
The parties hereto agree that irreparable damage would occur if for any reason any party fails to perform any of its obligations
under this Agreement and that the opposing parties may not have an adequate remedy at law for money damages in such event. Accordingly,
the parties shall be entitled to specific performance and injunctive and other equitable relief to prevent breaches of this Agreement
or to enforce specifically the performance of the terms and provisions hereof in any Delaware Court, in addition to any other remedy
to which they are entitled at law or in equity, in each case without posting bond or other security, and without the necessity
of proving actual damages.

 

4.10 Headings.
The Section headings contained in this Agreement are solely for the purpose of reference, are not part of the agreement of the
parties, and will not in any way affect the meaning or interpretation of this Agreement.

 

4.11 No Presumption.
The parties have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity or question
of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties and no presumption or
burden of proof will arise favoring or disfavoring any party by virtue of the authorship of any of the provisions of this Agreement.

 

4.12 Further Assurances.
Each of the parties hereto will execute and deliver, or cause to be executed and delivered, all further documents and instruments
and use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all
things necessary under applicable Law to perform their respective obligations as expressly set forth under this Agreement.

 

4.13 Interpretation.
Unless the context otherwise requires, any reference to a “Section” will be deemed to refer to a Section of this
Agreement. The words “hereof,” “herein” and “hereunder” and words of similar import referring
to this Agreement refer to this Agreement as a whole and not to any particular provision of this Agreement. The word “including”
or any variation thereof means “including, without limitation” and will not be construed to limit any general statement
that it follows to the specific or similar items or matters immediately following it. Any reference to any federal, state, local
or foreign statute or law will be deemed also to refer to all rules and regulations promulgated thereunder, unless the context
requires otherwise. All terms defined in this Agreement will have the defined meanings when used in any certificate or other document
made or delivered pursuant hereto unless otherwise defined therein. The definitions contained in this Agreement are applicable
to the singular as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of
such term.

 

4.14 Capacity as Shareholder.
Each Shareholder signs this Agreement solely in such Shareholder’s capacity as a Parent Shareholder, and not in such Shareholder’s
capacity as a director, officer or employee of Parent or in such Shareholder’s capacity as a trustee or fiduciary of any
employee benefit plan or trust. Notwithstanding anything herein to the contrary, nothing herein shall in any way restrict a director
or officer of Parent in the exercise of his or her fiduciary duties as a director or officer of Parent or in his or her capacity
as a trustee or fiduciary of any employee benefit plan or trust, or prevent any director or officer of Parent or any trustee or
fiduciary of any employee benefit plan or trust from taking any action in his or her capacity as such director, officer, trustee
or fiduciary.

 

    	 	6	 

     

    

 

4.15 Conversion or
Exercise. Nothing contained in this Agreement shall require any Shareholder (or shall entitle any proxy of any Shareholder)
to (a) convert, exercise or exchange any option, warrants or convertible securities in order to obtain any underlying Subject Shares
or (b) vote, or execute any consent with respect to, any Subject Shares underlying such options, warrants or convertible securities
that have not yet been issued as of the applicable record date for that vote or consent.

 

4.16 Representations
and Warranties. The representations and warranties contained in this Agreement and in any certificate or other writing delivered
pursuant hereto shall not survive the Closing or the termination of this Agreement.

 

4.17 No Agreement
Until Executed. Irrespective of negotiations among the parties or the exchanging of drafts of this Agreement, this Agreement
shall not constitute or be deemed to evidence a contract, agreement, arrangement or understanding between the parties hereto unless
and until (a) the Parent Board has approved, for purposes of any applicable anti-takeover laws and regulations, and any applicable
provision of Parent’s organizational documents, the possible acquisition of the Company by Parent pursuant to the Merger
Agreement and (b) the Merger Agreement is executed by all parties thereto.

 

(SIGNATURE
PAGES FOLLOW)

 

    	 	7	 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Agreement to be duly executed as of the date first written above.

 

	 	XYNOMIC PHARMACEUTICALS, INC.
	 	 
	 	By:	/s/ Yinglin
    Mark Xu                   
	 	Name:	Yinglin
    Mark Xu
	 	Title:	Chairman, Chief Executive Officer

and President

 

     

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Agreement to be duly executed as of the date first written above.

 

	 	BISON CAPITAL HOLDING COMPANY LIMITED
	 	 
	 	By:	/s/     Peixin
    Xu                   
	 	Name: 	Peixin
    Xu
	 	Title:	Director
	 	 
	 	James Jiayuan Tong
	 	 
	 	/s/ James
    Jiayuan Tong

 

     

     

    

 

Schedule A

 

 

	Name of Shareholder	 	No. of Parent Ordinary Shares Beneficiary Owned	 
	 	 	 	 
	Bison Capital Holding Company Limited	 	 	1,117,725	 
	James Jiayuan Tong	 	 	391,650

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00287-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00287-of-00352.parquet"}]]